Stay updated with breaking news from Special Access Route. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Japanese pharmaceutical company Shionogi has announced the first peer-reviewed publication of its phase 3 study investigating ensitrelvir to treat patients with mild to moderate COVID-19 in Japan, South Korea and Vietnam.
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced the first peer-reviewed publication of the Phase 3 portion of its pivotal, double-blind, randomized, placebo-controlled...
Singapore News - When their son started gagging and refusing his food at about eight months old, the first-time parents knew something was amiss. A month later, Baby Shamel was not able to sit up and showed no signs of being able to put weight on his legs. Soon after, he lost the... Read more at www.tnp.sg
The disorder may affect one's ability to swallow, suck, and breathe.
A five-month-old boy facing immobility or even death because of a rare genetic disorder may get a new lease of life after his parents successfully raised the $3 million needed for a drug to treat his condition. Baby Zayn - who was diagnosed with Type 1 spinal muscular atrophy (SMA) at about five weeks old - will be able to...